J&J’s Depuy to Stop Selling all Custom Devices After Receiving FDA Warning Letter

      J&J's Depuy to stop selling all custom devices in response to FDA warning (MassDevice) Johnson & Johnson subsidiary Depuy Orthopaedics decides to stop selling all custom devices following an FDA letter warning the company to file new PMA and 510(k) applications for several components. Johnson & Johnson subsidiary DePuy Orthopaedics decided to stop selling all custom fitted devices in response to an FDA warning following an inspection of the Warsaw, Ind.-based company's facilities. This week the FDA's Centers for Devices & Radiological Health released a letter wa...


Unlock the full article and exclusive OrthoStreams insights: in-depth analyses, hot startups, trends, market intel, and Daily Newsletter—for just $1/day.
Subscribe Now—Up your Game !
 

Scroll to Top